Chorea, Huntington
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Open-Label Rollover Study for Continuing Valbenazine Administration for the Treatment of Chorea Associated With Huntington Disease (NCT04400331) | Neurocrine Biosciences | 2020-09-18 |
| Efficacy, Safety, and Tolerability of Valbenazine for the Treatment of Chorea Associated With Huntington Disease (NCT04102579) | Neurocrine Biosciences | 2019-11-13 |
Track Chorea, Huntington automatically
Every clearance here is in the API, with alerts when new ones post.